The following is a statement from the American Cancer Society Cancer Action Network (ACS CAN), the American Heart Association, the American Lung Association and the Leukemia & Lymphoma Society® (LLS) in reaction to the Mississippi conference report released late Monday night that creates barriers through work requirements for people who need health insurance.
Today, the Food and Drug Administration (FDA) finalized a new rule regulating laboratory developed tests (LDTs) that will harmonize oversight for diagnostic tests regardless of whether tests are performed in individual laboratories or sold as prepackaged kits.
The following is a statement from Dr. Karen E. Knudsen, CEO of the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN), on the passing of U.S. Representative Donald M. Payne Jr. (D-N.J.).
Today, the U.S. Department of Agriculture Food and Nutrition Service finalized a new rule to revise the child nutrition program standards to ensure school meals are better aligned with the U.S. Dietary Guidelines for Americans and based on the latest nutritional science.
In light of the recent news regarding Dr. Francis Collins, former director of the National Institutes of Health (NIH), and his recent prostate cancer diagnosis, the American Cancer Society (ACS) extends its full support as he navigates his cancer journey.
Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network and peer institutions released new findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer, or 21.9%, participate in some form of clinical research.
Today, the White House again failed to meet their own deadline to finalize the U.S. Food and Drug Administration (FDA) proposed rules to end the sale of menthol cigarettes and eliminate all flavors in cigars despite an overwhelming amount of evidence demonstrating menthol flavoring is a serious public health risk.
In a major victory for public health, a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit has unanimously upheld graphic health warnings on cigarette packs and advertising required under a 2020 FDA rule.
WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program.
Today, the American Cancer Society Cancer Action Network submitted a statement for the record to the House Energy & Commerce Committee Health Subcommittee in regards to their hearing on Evaluating Approaches to Diagnostic Test Regulation and the impact of the FDA’s proposed rule.